<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel>
<title>marked.bio: PIK3CA activating mutation</title><link>https://marked.bio/biomarker/pik3ca-mut/index.html</link>
<description>Weekly changes in PIK3CA activating mutation trials and approvals.</description><language>en</language>
<item><title>PIK3CA activating mutation, week to 27 October 2026: 1 new trial</title><link>https://marked.bio/biomarker/pik3ca-mut/index.html#whats-new</link><guid isPermaLink="false">marked.bio-pik3ca_mut-2026-10-27</guid><pubDate>Tue, 27 Oct 2026 12:00:00 +0000</pubDate><description>&lt;p&gt;&lt;b&gt;1 new trial&lt;/b&gt; on marked.bio between 20 October 2026 and 27 October 2026.&lt;/p&gt;&lt;h3&gt;New trials (1)&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;&lt;a href=&quot;https://clinicaltrials.gov/study/NCT07897721&quot;&gt;A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors&lt;/a&gt; (Phase 1, Pfizer) &lt;i&gt;PIK3CA activating mutation&lt;/i&gt;&lt;/li&gt;&lt;/ul&gt;</description></item>
</channel></rss>